This study exists to see whether the medication OPC-14597 can make care clearer and more responsive. Researchers are trying to understand whether the medication OPC-14597 can better prevent setbacks and support longer-term stability.
In Canada
BipolarityDrugFrom 18 Years to 65 Years
Countries
United States, Canada, Japan, ...
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
This study is looking at whether cognitive behavioural therapy can help people with Depression, Anxiety, or PTSD. Participants take part in cognitive behavioural therapy and complete follow-up assessments.
In Canada
PTSD, Depression, ...DeviceA study involving a tool, app, wearable, test, or medical device.Over 18 Years
This study is looking at further assess ERG components obtained with different ERG devices, to be considered in a prediction model for each diagnosis for people with Schizophrenia or Bipolarity I. Participants are followed over time so researchers can learn from clinical and follow-up information.
In Canada
Bipolarity, SchizophreniaDeviceFrom 18 Years to 50 Years
HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.